Your browser doesn't support javascript.
loading
Temporal Association of Atrial Fibrillation With Cardiac Implanted Electronic Device Detected Heart Failure Status.
Capucci, Alessandro; Wong, Jorge A; Gold, Michael R; Boehmer, John; Ahmed, Rezwan; Kwan, Brian; Thakur, Pramodsingh H; Zhang, Yi; Jones, Paul W; Healey, Jeffrey S.
  • Capucci A; Clinica di Cardiologia e Aritmologia, Università Politecnica delle Marche, Ancona, Italy. Electronic address: profacapucci@gmail.com.
  • Wong JA; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Gold MR; Medical University of South Carolina, Charleston, South Carolina, USA.
  • Boehmer J; The Penn State Hershey Medical Center, Hershey, Pennsylvania, USA.
  • Ahmed R; Boston Scientific Corporation, St. Paul, Minnesota, USA.
  • Kwan B; Boston Scientific Corporation, St. Paul, Minnesota, USA.
  • Thakur PH; Boston Scientific Corporation, St. Paul, Minnesota, USA.
  • Zhang Y; Boston Scientific Corporation, St. Paul, Minnesota, USA.
  • Jones PW; Boston Scientific Corporation, St. Paul, Minnesota, USA.
  • Healey JS; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
JACC Clin Electrophysiol ; 8(2): 182-193, 2022 02.
Article en En | MEDLINE | ID: mdl-35210075
ABSTRACT

OBJECTIVES:

This study sought to investigate the temporal association between changes in physiologic heart failure (HF) sensors, atrial fibrillation (AF) progression, and clinical HF in patients with cardiac resynchronization therapy implantable defibrillators (CRT-D) designed to monitor AF and HF daily.

BACKGROUND:

AF is a common comorbidity in HF; however, it is unclear if HF triggers AF, or vice-versa. Current implantable cardiac devices have sensors capable of quantifying HF status, which permits a greater understanding of the impact of AF on HF status and may help guide treatment.

METHODS:

The MultiSENSE (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients) study collected multiple sensor data indicative of HF status in patients with CRT-D followed for up to 12 months. Patients were grouped according to their longest daily AF burden 1) at least 24 hours of AF (HIGH AF); 2) between 6 minutes and 24 hours (MID AF); and 3) <6 minutes (NO AF). Sensor data were aligned to the first qualifying AF event or a randomly selected day for patients in the NO AF group.

RESULTS:

Among 869 patients with daily AF data available, 98 patients had HIGH AF, 141 patients MID AF, and 630 patients NO AF. At baseline, history of AF, N-terminal pro hormone B-type natriuretic peptide and device-measured S3 were associated with development of AF. HeartLogic index increased before AF onset (Δ HeartLogic = 9.83 ± 2.49; P < 0.001). Multivariable time-dependent Cox regression showed an increased risk for HF events following a 24-hour AF episode compared with no 24-hour AF (hazard ratio 1.96; 95% confidence interval 1.03-3.74).

CONCLUSIONS:

Device-measured HF indicators worsened before AF onset, whereas clinical HF deterioration only became apparent after AF occurred. Thus, the sensitivity of methods to ascertain AF and HF status appear to influence the direction of perceived causality. (Multisensor Chronic Evaluation in Ambulatory Heart Failure Patients [MultiSENSE]; NCT01128166).
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Desfibriladores Implantables / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Desfibriladores Implantables / Insuficiencia Cardíaca Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article